On Invalid Date, Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) reported Q4 2023 earnings per share (EPS) of -$0.35, up 39.66% year over year. Total Reviva Pharmaceuticals Holdings earnings for the quarter were -$9.72 million. In the same quarter last year, Reviva Pharmaceuticals Holdings's earnings per share (EPS) was -$0.58.
As of Q2 2024, Reviva Pharmaceuticals Holdings's earnings has grown year over year. Reviva Pharmaceuticals Holdings's earnings in the past year totalled -$39.26 million.
What is RVPH's earnings date?
Reviva Pharmaceuticals Holdings's earnings date is Invalid Date. Add RVPH to your watchlist to be reminded of RVPH's next earnings announcement.
What was RVPH's revenue last quarter?
On Invalid Date, Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Reviva Pharmaceuticals Holdings's revenue was $0.00.
What was RVPH's revenue growth in the past year?
As of Q2 2024, Reviva Pharmaceuticals Holdings's revenue has grown null year over year. Reviva Pharmaceuticals Holdings's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.